Dhaka, Sep 2 (IANS) Three more people have died due to dengue in Bangladesh in the past 24 hours till Tuesday morning, increasing the number of deaths from the mosquito-borne disease in the country to 125, this year.
New Delhi, Sep 2 (IANS) More than 1 crore people globally live with a mental health disorder, and women account for over 53 per cent, according to new data released by the World Health Organization (WHO) on Tuesday.
New Delhi, Sep 2 (IANS) Zydus Lifesciences on Tuesday launched India’s first trivalent influenza vaccine, aligning with the global recommendations of the World Health Organization (WHO).
New Delhi, Sep 2 (IANS) Niva Bupa Health Insurance on Tuesday clarified that the viral social media post regarding the cashless denial of a Mumbai-based policyholder is ‘baseless’.
New Delhi, Sep 2 (IANS) India must become self-reliant in manufacturing technologies that can help remove disabilities such as speech and hearing and make them more accessible to the common man, said President Droupadi Murmu.
Patna, Sep 1 (IANS) The Pradhan Mantri National Dialysis Programme (PMNDP) launched in 2016-17, to provide dialysis services free of cost to people below the Poverty Line (BPL) is proving to be boon for people in Sheikhpura and adjoining districts of Bihar.
New Delhi, Sep 1 (IANS) As thousands of health policyholders in India are suffering due to loss of access to cashless hospitalisation, the Association of Healthcare Providers - India (AHPI) on Monday asked health insurance firms to revoke suspension and create an affordable as well as sustainable model.
New Delhi, Sep 1 (IANS) With 23 of the world’s top 50 life sciences companies establishing centres in the country, India has emerged as the global hub of Global Capability Centers (GCCs) for life sciences, according to a report on Monday.
New Delhi, Sep 1 (IANS) In a move that could impact thousands of patients, Niva Bupa Health Insurance on Monday said it has suspended the cashless treatment facility at Max Hospitals across India.
New Delhi, Aug 30 (IANS) Beta blockers, the standard treatment after a heart attack for the last 40 years, may offer no benefit for heart attack patients and can raise death risk in some women, according to a study on Saturday that called for a rejig into the standard treatment paradigm.
